Latest News

Geriatric assessments improve oncologist-patient communications


 

REPORTING FROM ASCO 2018

CHICAGO – Elderly cancer patients have better communication with their oncologists and report greater satisfaction with their care when the oncologists are provided with geriatric assessment summaries prior to the patient visit.

Although “satisfaction” can be subjective, the conclusion about the benefit of previsit geriatric assessments is objective, reported Supriya Gupta Mohile, MD, of the University of Rochester, New York.

Dr. Supriya Gupta Mohile, of the University of Rochester, New York Neil Osterweil/MDedge News

Dr. Supriya Gupta Mohile

Dr. Mohile and her colleagues conducted a cluster randomized controlled study of 542 patients aged 70 or older. “Most older patients with advanced cancer want treatment, but only if it does not negatively affect other health issues,” she said at a briefing at the annual meeting of the American Society of Clinical Oncology.

“Physicians often don’t know patients’ and caregivers’ age-related concerns, such as concerns about memory or concerns about falling. Many patients and caregivers do not ask about age-related concerns, because of their unclear understanding of the relevance of those issues to an oncology clinical encounter,” she added.

The aim of the researchers was to see whether communication between physicians and their elderly patients could be improved, and patient support needs addressed, with the aid of the Geriatric Assessment (GA), a multidisciplinary diagnostic and treatment instrument.

The GA evaluates patients in the domains of functional status, objective physical performance, comorbidities, cognition, nutritional status, psychological status, and social support, and identifies vulnerabilities that could be addressed by specific interventions.

For example, patients with suboptimal physical performance may trigger recommendations for fall prevention and a review of medications that could increase fall risk. For patients with decrements in functional status, recommendations may include physical therapy, safety evaluation, and/or vision assessment.

Pages

Recommended Reading

CRC recurrence surveillance studies: No benefit to high-intensity strategy
MDedge Hematology and Oncology
New remote monitoring system lessens symptoms in head and neck cancer
MDedge Hematology and Oncology
FDA advisory panelists reject Buvaya for acute pain
MDedge Hematology and Oncology
CBT-I bests acupuncture for treating insomnia among cancer survivors
MDedge Hematology and Oncology
Ketorolac may reduce breast cancer recurrence risk, particularly in overweight patients
MDedge Hematology and Oncology
Dermatologic complaints prolong hospital stay for hematologic cancer
MDedge Hematology and Oncology
In CRC patients, chemo yields more toxicities in women than in men
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Tumor analysis: Test all MSI-high patients for Lynch Syndrome
MDedge Hematology and Oncology
David Henry’s JCSO podcast, May-June 2018
MDedge Hematology and Oncology